Clindamycin Phosphate

ANDA 62930, held by Vintage Pharms. Clindamycin Phosphate.

As of Nov 15, 2026, ANDA 62930 (Clindamycin Phosphate), held by Vintage Pharms, was first approved by FDA on Jun 28, 1989, with 8 approved supplements and 0 published complete response letters.

First approved: Jun 28, 1989
Supplements approved: 8
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 9 submissions below

Date	Submission	Status	Documents
Jun 28, 1989	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Clindamycin PhosphateEQ 1% BASE · solution;topical	Clindamycin Phosphate	Discontinued

All 9 submissions, including labeling and manufacturing supplements


Aug 30, 2001	Supplement 8Manufacturing	Approved	None posted
May 4, 1995	Supplement 7Manufacturing	Approved	None posted
May 4, 1995	Supplement 6Manufacturing	Approved	None posted
Mar 21, 1994	Supplement 4Labeling	Approved	None posted
Mar 21, 1994	Supplement 3Manufacturing	Approved	None posted
Aug 31, 1993	Supplement 5Manufacturing	Approved	None posted
Apr 1, 1993	Supplement 2Manufacturing	Approved	None posted
Feb 11, 1993	Supplement 1Manufacturing	Approved	None posted
Jun 28, 1989	Original application	Approved	None posted

Identifiers

Application: ANDA 62930
Drugs@FDA: Overview at FDA
Company: Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters